Advertisement

Topics

EMA committee recommends Baxalta's Adynovi for bleeding in hemophiliacs

06:11 EST 13 Nov 2017 | SmartBrief

A recommendation for approval was given by the European Medicines Agency's Committee for Medicinal Products for Human Use for -More

Original Article: EMA committee recommends Baxalta's Adynovi for bleeding in hemophiliacs

NEXT ARTICLE

More From BioPortfolio on "EMA committee recommends Baxalta's Adynovi for bleeding in hemophiliacs"

Advertisement
Quick Search
Advertisement
Advertisement